Fortis Life Sciences Acquires nanoComposix

Fortis Life Sciences has completed its acquisition of nanoComposix, a premium nanomaterials company focused on solutions for assay development and diagnostics.  Since 2004, nanoComposix has built one of the most comprehensive nanomaterials portfolios in the industry.  nanoComposix’s nanomaterials are used in a wide array of Life Sciences applications, including drug delivery, diagnostics and imaging, as well as industrial applications.

The combination of nanoComposix with other Fortis portfolio companies will lead to a powerful synergy within the life science reagent space.  CEO Brian Kim commented on the partnership stating, “We are excited to have nanoComposix join the Fortis Life Sciences platform, and partner with the bright and talented team in San Diego to create and commercialize high-impact nanotechnology products.”

nanoComposix CEO, Steve Oldenburg, Ph.D. founded the company with a vision of combining precisely engineered and highly characterized nanomaterials together with a multi-disciplinary team of innovative scientists to produce and bring to market nano-enabled products with unparalleled performance.  Recently, nanoComposix focused its efforts on the life sciences market and has seen rapid adoption of its nanoparticles in a wider variety of diagnostic and therapeutic applications.  Commenting on the partnership with Fortis, Dr. Oldenburg stated “Combining our unique nanoparticle products with accelerated development services has led to an explosion of interest in our nanoparticles and their applications.  Fortis is the perfect growth partner for us to continue to provide our customers with world-class support in this dynamic market. ”

The transaction closed in June 2021.

About nanoComposix

Founded in 2004, nanoComposix is headquartered in San Diego, CA, USA. nanoComposix was built with the mission of providing precisely engineered and highly characterized nanomaterials to a global customer base. The product portfolio contains hundreds of different variants of materials, size, shape, and surface backed by extensive technical documentation and support.  Development services are provided by a technical team with extensive expertise in nanotechnology, biology, chemistry, physics, and optics.  nanoComposix produced the NIST nanosilver reference material and its materials have been utilized in over 3000 peer-reviewed publications. nanoComposix is an ISO 13485 certified* company. This helps to ensure that our products and services are of the highest quality and continue to meet customer expectations.

About Fortis Life Sciences

Fortis Life Sciences® partners with diagnostics and life sciences companies to design, validate, and manufacture solutions to solve their complex development problems. Fortis’ tailored approach and end-to-end capabilities accelerate the work of its customers as they bring the next generation of medicines and diagnostics to market. Fortis serves a global customer base and has offices across North America including four R&D sites and three GMP and ISO 13485 compliant manufacturing facilities.

*For products within the scope of our ISO certification.